MedTrace Logo

Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria

NCT04264234 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2022-03-23

No results posted yet for this study

Summary

Placenta previa cases are one of the difficult groups of patients to manage in modern obstetrics. When the literature is evaluated extensively, no clear information can be seen especially in terms of hospitalization time. Inpatient follow-up of this patients has negative effects like hospital infections in terms of the patient, workload in terms of health personnel and financial losses in terms of the country's economy. Placenta previa cases are complicated patients in which generalizations cannot be easily performed and they should be monitored at third level hospitals. In addition, care should be personalized considering the many reasons. In this study, placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery. Thus, in this study, it was aimed to determine the parameters that would allow systematic personalization of health service in this particular patient group by making risk assessment of placenta previa cases.

Conditions

  • Placenta Previa

Interventions

DIAGNOSTIC_TEST

Vaginal Ultrasonography

Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography for invasion anomaly and preterm birth.

DIAGNOSTIC_TEST

Magnetic Resonance Imaging

Placenta previa cases will be evaluated at 32nd week by MRI for invasion anomaly and preterm birth.

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Sabahattin a Arı, MD · Ege University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-13
Primary Completion
2020-02-01
Completion
2020-02-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04264234 on ClinicalTrials.gov